Latest Off-label use Stories
National network of attorneys initiates offer of no-cost consultations to consumers seeking compensation for allegations of gynecomastia, other side effects. San
The U.S. Food and Drug Administration reports it has notified health professionals about a new Black Box warning for Pfizer Inc.'s intravenous antibacterial drug Tygacil (tigecycline).
Parker Waichman LLP is concerned that the public has not been properly educated about the clinically proven potential side effects that could result from Medtronic’s Infuse bone graft product.
Johnson & Johnson is appealing the $1.2 billion fine issued by an Arkansas court over off-label marketing claims the company supposedly made regarding its antipsychotic drug Risperdal.
Migraine headaches are a major cause of ill health and a reduced quality of life.
Pharmaceutical health services research goes beyond studying the effects of individual drugs, to looking at the complex and interrelated effects of medications on the health of patients and the population.
"Off label" drugs are medications that have not been tested for safety or efficacy for a specific patient age or condition.